Robert S. Benjamin
Impact in
- Gastroenterology top 0.02%
- Gastrointestinal Tumor Research and Treatment
- Pulmonary and Respiratory Medicine top 0.05%
- Sarcoma Diagnosis and Treatment
- Gastric Cancer Management and Outcomes
Papers in
-
- Sarcoma Diagnosis and Treatment 191
- Oncology 165
- Cancer Treatment and Pharmacology 47
- Vascular Tumors and Angiosarcomas 40
- Co-authors
- SHREYASKUMAR R. PATEL (92 shared papers)Raphael E. Pollock (45 shared papers)Peter W. T. Pisters (31 shared papers)Sewa S. Legha (42 shared papers)Haesun Choi (13 shared papers)Nicholas R. Bachur (7 shared papers)Gunar K. Zagars (21 shared papers)Matthew T. Ballo (19 shared papers)
- Journals
- Cancer (77 papers)Journal of Clinical Oncology (38 papers)Clinical Cancer Research (11 papers)Journal of the National Comprehensive Cancer Network (10 papers)International Journal of Radiation Oncology*Biology*Physics (7 papers)
- Partner nations
- United StatesItalyUnited Kingdom
In The Last Decade
Robert S. Benjamin
487 papers receiving 29.9k citations
Robert S. Benjamin's Hit Papers
Peers
Comparison fields: 5 of 151
- Gastroenterology 4.6k
- Pulmonary and Respiratory Medicine 14.2k
- Oncology 10.8k
- Rheumatology 3.6k
- Cardiology and Cardiovascular Medicine 5.3k
Countries citing papers authored by Robert S. Benjamin
This map shows the geographic impact of Robert S. Benjamin's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Robert S. Benjamin with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Robert S. Benjamin more than expected).
Fields of papers citing papers by Robert S. Benjamin
This network shows the impact of papers produced by Robert S. Benjamin. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Robert S. Benjamin. The network helps show where Robert S. Benjamin may publish in the future.
Co-authors
The 25 scholars most cited alongside Robert S. Benjamin, linked wherever they have co-authored with each other. Click a name or a connecting line to browse the papers they share.
All Works
Showing the 20 most-cited of 499 papers — load more, or switch the sort, to bring in the rest.
| # | Work | ||
|---|---|---|---|
| 1 | Correlation of Computed Tomography and Positron Emission Tomography in Patients With Metastatic Gastrointestinal Stromal Tumor Treated at a Single Institution With Imatinib Mesylate: Proposal of New Computed Tomography Response Criteria Hit paper breakdown → | 2007 | 1232 |
| 2 | Phase III Randomized, Intergroup Trial Assessing Imatinib Mesylate At Two Dose Levels in Patients With Unresectable or Metastatic Gastrointestinal Stromal Tumors Expressing the Kit Receptor Tyrosine Kinase: S0033 Hit paper breakdown → | 2008 | 861 |
| 3 | Phase I Safety and Pharmacokinetic Study of Recombinant Human Anti-Vascular Endothelial Growth Factor in Patients With Advanced Cancer Hit paper breakdown → | 2001 | 799 |
| 4 | Reduction of Doxorubicin Cardiotoxicity by Prolonged Continuous Intravenous Infusion Hit paper breakdown → | 1982 | 661 |
| 5 | Randomized Phase II Study of Gemcitabine and Docetaxel Compared With Gemcitabine Alone in Patients With Metastatic Soft Tissue Sarcomas: Results of Sarcoma Alliance for Research Through Collaboration Study 002 Hit paper breakdown → | 2007 | 608 |
| 6 | Soft Tissue Sarcoma, Version 2.2018, NCCN Clinical Practice Guidelines in Oncology Hit paper breakdown → | 2018 | 558 |
| 7 | Prognostic factors for patients with localized soft‐tissue sarcoma treated with conservation surgery and radiation therapy Hit paper breakdown → | 2003 | 558 |
| 8 | NCCN Task Force Report: Management of Patients with Gastrointestinal Stromal Tumor (GIST)—Update of the NCCN Clinical Practice Guidelines Hit paper breakdown → | 2007 | 503 |
| 9 | Correlation of Kinase Genotype and Clinical Outcome in the North American Intergroup Phase III Trial of Imatinib Mesylate for Treatment of Advanced Gastrointestinal Stromal Tumor: CALGB 150105 Study by Cancer and Leukemia Group B and Southwest Oncology Group Hit paper breakdown → | 2008 | 492 |
| 10 | We Should Desist Using RECIST, at Least in GIST Hit paper breakdown → | 2007 | 467 |
| 11 | 2004 | 376 | |
| 12 | 1974 | 353 | |
| 13 | 2014 | 338 | |
| 14 | 2012 | 319 | |
| 15 | 2002 | 300 | |
| 16 | 2004 | 293 | |
| 17 | 1995 | 275 | |
| 18 | 2011 | 275 | |
| 19 | Adriamycin (NSC 123127) cardiomyopathy. An overview with determination of risk factors | 1975 | 251 |
| 20 | 1997 | 245 |
About Robert S. Benjamin
Robert S. Benjamin is a scholar working on Pulmonary and Respiratory Medicine, Oncology, Cardiology and Cardiovascular Medicine, Gastroenterology and Rheumatology, having authored 499 papers that have together received 31.8k indexed citations. Recurring topics across this work include Sarcoma Diagnosis and Treatment (191 papers), Chemotherapy-induced cardiotoxicity and mitigation (50 papers), Cancer Treatment and Pharmacology (47 papers), Gastrointestinal Tumor Research and Treatment (44 papers), Vascular Tumors and Angiosarcomas (40 papers), Cardiac tumors and thrombi (38 papers), Bone Tumor Diagnosis and Treatments (27 papers) and Cancer therapeutics and mechanisms (24 papers). The work is most often cited by research in Gastroenterology (4.6k citations), Pulmonary and Respiratory Medicine (14.2k citations), Oncology (10.8k citations), Rheumatology (3.6k citations) and Cardiology and Cardiovascular Medicine (5.3k citations). Robert S. Benjamin has collaborated with scholars based in United States, Italy and United Kingdom. Frequent co-authors include SHREYASKUMAR R. PATEL, Raphael E. Pollock, Peter W. T. Pisters, Sewa S. Legha, Haesun Choi, Nicholas R. Bachur, Gunar K. Zagars, Matthew T. Ballo, Carl Plager and Homer A. Macapinlac. Their work appears in journals such as Cancer, Journal of Clinical Oncology, Clinical Cancer Research, Journal of the National Comprehensive Cancer Network and International Journal of Radiation Oncology*Biology*Physics.
Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.